1.
Gynecol Oncol Rep
; 22: 43-44, 2017 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29034306
RESUMO
â¢A case report of a 14 year remission of recurrent ovarian cancer with intraperitoneal aldesleukin (IL-2) is presented.â¢Intraperitoneal IL-2 was given with little toxicity.â¢Immunotherapy may have the potential for durable remissions in ovarian cancer.